The future of breast cancer screening and risk-reducing strategies is being shaped by artificial intelligence (AI), according ...

The future of breast cancer screening and risk-reducing strategies is being shaped by artificial intelligence (AI), according to a recent review article.

Icad (NASDAQ: ICAD) Presents Four AI-Driven Breast Cancer Research Abstracts at the 2024 San Antonio Breast Cancer Symposium ...

Researchers have successfully developed a deep learning model that classifies pancreatic ductal adenocarcinoma (PDAC), the ...

A new AI-powered blood test is the first to detect signs of breast cancer in its earliest stages when it is “far more easily treated”, scientists have announced. The new non-invasive test works by ...

Some early breast cancer patients can safely avoid specific surgeries, according to two studies exploring ways to lessen treatment burdens.

Two recent studies explore options for early-stage breast cancer patients to reduce surgery. One suggests active monitoring ...

More than 100 000 women older than 70 years are diagnosed with hormone receptor-positive, early-stage breast cancer each year in the USA.1 A large proportion are at low risk of disease recurrence, ...

Project EVOLVE, funded by Daiichi Sankyo and AstraZeneca, to be presented at the 2024 San Antonio Breast Cancer Symposium -- NEW YORK, Dec. 12, 2024 /PRNewswire/ -- Novellia, Inc., an AI-enabled ...

Data from a late-stage study shows that LLY's experimental oral drug benefited certain breast cancer patients when used as ...

A HER2-positive status reflects breast cancer cells with extra copies of the HER2 gene, or higher expression of HER2 proteins ...